In order to study the amount of blood lost, the number of transfusions and the effectiveness of preoperative autologous blood donation in lung cancer surgery, 108 patients' records from 1993 to 1995 were reviewed in our Institute; 36 patients who donated blood for autologous use (Group A) and 72 patients who did not donated blood for autologous use (Group B) were included. In the Group A the calculated red cell volume lost ("EBL") was 479(286* mL (30(16%)*, in the Group B it was 406(254* mL (22(13%)*, in the patients who did not received any transfusion it was 365(184* mL (20(8%)* and 350(193* mL (19(8%)* respectively; in the patients who received either autologous or allogeneic blood EBL was 1082(270* mL (64(9%)*; in the patients who received allogeneic blood only EBL was 902(180* mL (50(13%)*, in the patients who received autologous blood only it was 452(114* mL (32(8%)*. 45 RBCs units were donated from the Group A patients, 21 of which (46%) were transfused during surgery or the following 48-72 hours; 13 patients (36%) from the Group A received autologous RBCs only; 19 patients from the Group A (53%) and 65 from the Group B (90%) did not received any transfusion, 4 patients from the Group A (11%) and 7 from the Group B (10%) received allogeneic blood. The preoperative/pretransfusion Ht decrease was 9,2% (36,0/26,8%)° in the 13 patients who received autologous only; it was 12,8% (37,7/24,9%)° in the 4 patients who received either autologous or allogeneic blood and 17,8% (41,1/23,3%)° in the 7 patients who received blood only. Autologous blood donors were overtransfused in comparison with the patients who did not donated blood for autologous use, while the use of allogeneic blood was always correct, if correlated with the Ht decrease; consequently the autologous blood predeposit is shown to be almost useless in cancer patients who underwent thoracic surgery.
|Number of pages||1|
|Journal||Infusionstherapie und Transfusionsmedizin|
|Publication status||Published - 1997|
ASJC Scopus subject areas
- Food Science